Clinical Trial Update: Aromatase Inhibitor Host Factors Study [NA]

View source ↗

Summary

A completed clinical trial update for an aromatase inhibitor study investigating host factors in breast neoplasms; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Snippet

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Conditions: Breast Neoplasms | NA | Status: COMPLETED | Results posted: 2021-05-13